Jaideep J Iyengar, MD
Orthopedic Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 3 carriers
- Offices
- 3
Offices
3 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: 059796 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
21 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Iyengar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A103986 · Current
Licensed to practise in California · since 2008 · expires 2027-12-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60097526Physician And Surgeon License · since 2009 · expires 2015-12-31ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$112,643
Medicare paid this office $112,643 for 297 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 126 | $18,382 | $146 |
| Return visit (30+ min) | 116 | $16,626 | $115 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $14,055 | $1,171 |
| Long return visit (40+ min) | 31 | $5,815 | $176 |
| Short return visit (20+ min) | 64 | $5,468 | $80 |
See all 10 services
| New patient visit (45+ min) | 126 | $18,382 | $146 |
| Return visit (30+ min) | 116 | $16,626 | $115 |
| Replacement of thigh bone and hip joint with prosthesis | 12 | $14,055 | $1,171 |
| Long return visit (40+ min) | 31 | $5,815 | $176 |
| Short return visit (20+ min) | 64 | $5,468 | $80 |
| Aspiration and/or injection of fluid from large joint | 58 | $4,011 | $62 |
| New patient visit (30+ min) | 33 | $3,402 | $103 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 17 | $3,214 | $189 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 15 | $214 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 57 | $197 | None |
Procedures Medicare counted
| Hip replacement | 13 | More than 55% of doctors who do this |
| Knee replacement | 15 | More than 45% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 15 | More than 54% of doctors who do this |
Who their Medicare patients are
297 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 16% · Women 65% · Also on Medicaid 15% · Health risk score 0.91. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 29% · Coronary heart disease 25% · Chronic kidney disease 19% · Depression 17% · Atrial fibrillation 14% · Cancer 11% · Heart failure 9% · COPD 9% · Stroke 8% · Dementia 7%.
The office billed $459,937, Medicare allowed $147,079 and paid $112,643; for 958 services of 39 kinds; $830 of it was for drugs given in the office and $111,813 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 297 | 958 | 75 | 0.91 | $459,937 | $112,643 |
| 2023 | 260 | 662 | 75 | 0.92 | $392,955 | $95,797 |
| 2022 | 264 | 1,187 | 75 | 1.03 | $425,268 | $102,545 |
| 2021 | 218 | 797 | 75 | 1.00 | $357,075 | $93,643 |
| 2020 | 132 | 447 | 74 | 1.02 | $102,081 | $26,308 |
| 2019 | 175 | 743 | 75 | 1.08 | $246,645 | $61,894 |
| 2018 | 190 | 1,040 | 74 | 1.19 | $285,656 | $68,316 |
| 2017 | 173 | 1,092 | 73 | 1.38 | $248,168 | $58,260 |
| 2016 | 150 | 687 | 72 | 1.06 | $209,374 | $52,455 |
| 2015 | 197 | 637 | 73 | 1.27 | $214,644 | $61,860 |
| 2014 | 174 | 442 | 73 | 1.10 | $147,007 | $43,905 |
| 2013 | 144 | 603 | 70 | 1.18 | $229,574 | $59,290 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 105 | $14,278 | $116 |
| New patient visit (45+ min) | 97 | $14,156 | $146 |
| Short return visit (20+ min) | 59 | $4,768 | $78 |
| Aspiration and/or injection of fluid from large joint | 47 | $2,667 | $54 |
| Long return visit (40+ min) | 19 | $2,524 | $133 |
| New patient visit (30+ min) | 22 | $2,260 | $103 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 46 | $168 | None |
2022: 8 services
| Replacement of knee joint, both sides of knee | 15 | $18,946 | $1,184 |
| New patient visit (45+ min) | 111 | $15,640 | $141 |
| Return visit (30+ min) | 100 | $14,422 | $115 |
| Short return visit (20+ min) | 58 | $4,363 | $69 |
| Aspiration and/or injection of fluid from large joint | 50 | $3,028 | $57 |
| Long return visit (40+ min) | 16 | $2,450 | $144 |
| New patient visit (30+ min) | 23 | $1,901 | $83 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 44 | $187 | None |
2021: 10 services
| Replacement of knee joint, both sides of knee | 13 | $16,949 | $1,211 |
| New patient visit (45+ min) | 93 | $13,978 | $150 |
| Return visit (30+ min) | 77 | $13,415 | $122 |
| Short return visit (20+ min) | 74 | $8,233 | $81 |
| Aspiration and/or injection of fluid from large joint | 53 | $3,853 | $64 |
| Long return visit (40+ min) | 16 | $3,512 | $167 |
| New patient visit (60+ min) | 13 | $2,486 | $191 |
| New patient visit (30+ min) | 24 | $2,277 | $95 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,625 | $86 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $138 | None |
2020: 7 services
| Short return visit (20+ min) | 57 | $5,041 | $64 |
| Return visit (30+ min) | 40 | $4,907 | $96 |
| New patient visit (30+ min) | 39 | $3,630 | $93 |
| New patient visit (45+ min) | 16 | $2,231 | $139 |
| Aspiration and/or injection of fluid from large joint | 31 | $2,162 | $57 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $785 | $71 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $70 | None |
2019: 8 services
| Return visit (30+ min) | 92 | $12,141 | $94 |
| Short return visit (20+ min) | 72 | $6,307 | $67 |
| New patient visit (30+ min) | 59 | $5,600 | $95 |
| New patient visit (45+ min) | 22 | $3,357 | $153 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 11 | $2,673 | None |
| Aspiration and/or injection of fluid from large joint | 40 | $2,606 | $50 |
| Injection, methylprednisolone acetate, 80 mg | 14 | $183 | None |
| Injection, methylprednisolone acetate, 40 mg | 18 | $110 | None |
2018: 7 services
| Return visit (30+ min) | 114 | $17,125 | $92 |
| New patient visit (30+ min) | 61 | $5,942 | $97 |
| Short return visit (20+ min) | 61 | $5,540 | $64 |
| New patient visit (45+ min) | 31 | $4,483 | $145 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,962 | $58 |
| Injection, methylprednisolone acetate, 80 mg | 22 | $295 | None |
| Injection, methylprednisolone acetate, 40 mg | 14 | $80 | None |
2017: 7 services
| Return visit (30+ min) | 104 | $14,681 | $86 |
| New patient visit (30+ min) | 64 | $5,654 | $88 |
| New patient visit (45+ min) | 28 | $3,536 | $126 |
| Aspiration and/or injection of fluid from large joint | 44 | $3,056 | $56 |
| Short return visit (20+ min) | 35 | $2,988 | $62 |
| Injection, methylprednisolone acetate, 80 mg | 21 | $232 | None |
| Injection, methylprednisolone acetate, 40 mg | 12 | $69 | None |
2016: 7 services
| Return visit (30+ min) | 90 | $14,292 | $88 |
| New patient visit (30+ min) | 51 | $4,302 | $84 |
| New patient visit (45+ min) | 30 | $4,277 | $143 |
| Short return visit (20+ min) | 36 | $3,362 | $60 |
| Aspiration and/or injection of fluid from large joint | 40 | $2,879 | $54 |
| Injection, methylprednisolone acetate, 80 mg | 19 | $163 | None |
| Injection, methylprednisolone acetate, 40 mg | 14 | $65 | None |
2015: 7 services
| Return visit (30+ min) | 111 | $19,244 | $102 |
| New patient visit (30+ min) | 93 | $9,105 | $98 |
| New patient visit (45+ min) | 36 | $5,651 | $157 |
| Aspiration and/or injection of fluid from large joint | 48 | $4,400 | $58 |
| Short return visit (20+ min) | 40 | $4,117 | $67 |
| Injection, methylprednisolone acetate, 80 mg | 24 | $151 | None |
| Injection, methylprednisolone acetate, 40 mg | 20 | $81 | None |
2014: 7 services
| Return visit (30+ min) | 84 | $12,234 | $98 |
| New patient visit (30+ min) | 74 | $7,084 | $96 |
| New patient visit (45+ min) | 33 | $4,894 | $148 |
| Short return visit (20+ min) | 43 | $3,273 | $64 |
| Aspiration and/or injection of fluid from large joint | 39 | $3,144 | $56 |
| Injection, methylprednisolone acetate, 80 mg | 26 | $143 | None |
| Injection, methylprednisolone acetate, 40 mg | 17 | $50 | None |
2013: 9 services
| Return visit (30+ min) | 82 | $9,064 | $76 |
| New patient visit (30+ min) | 51 | $3,889 | $76 |
| Aspiration and/or injection of fluid from large joint | 42 | $3,596 | $46 |
| New patient visit (45+ min) | 21 | $2,514 | $120 |
| Short return visit (20+ min) | 22 | $1,533 | $55 |
| X-ray of shoulder, minimum of 2 views | 44 | $1,289 | $24 |
| X-ray of knee, 4 or more views | 34 | $1,261 | $32 |
| Injection, methylprednisolone acetate, 80 mg | 22 | $136 | None |
| Injection, methylprednisolone acetate, 40 mg | 19 | $46 | None |
Drugs they prescribed that Part D paid
$2,262
Pharmacies billed $2,262 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (34 of 169) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
165 generic and fewer than 11 brand-name prescriptions · $2,262 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 28 | $475 | $14 |
| Meloxicam | 45 | $214 | $4 |
| Hydrocodone-Acetaminophen | 11 | $54 | $4 |
Year by year
| 2024 | 169 | 122 | 20% (34) | None | $2,262 |
| 2023 | 141 | 105 | 14% (19) | 0% | $2,574 |
| 2022 | 205 | 136 | 17% (34) | None | $4,849 |
| 2021 | 209 | 120 | 23% (49) | None | $3,126 |
| 2020 | 166 | 94 | 13% (22) | None | $2,942 |
| 2019 | 347 | 154 | 39% (136) | 3% | $8,224 |
| 2018 | 325 | 158 | 31% (99) | 4% | $7,209 |
| 2017 | 317 | 144 | 33% (105) | 6% | $6,868 |
| 2016 | 267 | 126 | 35% (94) | None | $4,601 |
| 2015 | 317 | 150 | 22% (71) | 5% | $6,073 |
| 2014 | 242 | 123 | 27% (65) | 12% | $5,327 |
| 2013 | 165 | 82 | 30% (50) | None | $3,727 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Diclofenac | 21 | $1,048 | $50 |
| Diclofenac | 12 | $299 | $25 |
| Meloxicam | 52 | $276 | $5 |
| Alendronate | 16 | $240 | $15 |
| Hydrocodone-Acetaminophen | 11 | $75 | $7 |
2022: 5 drugs
| Diclofenac | 34 | $1,884 | $55 |
| Diclofenac | 19 | $562 | $30 |
| Alendronate | 24 | $391 | $16 |
| Meloxicam | 70 | $279 | $4 |
| Hydrocodone-Acetaminophen | 22 | $130 | $6 |
2021: 5 drugs
| Diclofenac | 24 | $909 | $38 |
| Diclofenac | 16 | $750 | $47 |
| Meloxicam | 75 | $332 | $4 |
| Alendronate | 20 | $247 | $12 |
| Hydrocodone-Acetaminophen | 33 | $212 | $6 |
2020: 5 drugs
| Diclofenac | 33 | $1,198 | $36 |
| Diclofenac | 15 | $836 | $56 |
| Alendronate | 20 | $229 | $11 |
| Meloxicam | 60 | $190 | $3 |
| Hydrocodone-Acetaminophen | 15 | $125 | $8 |
2019: 6 drugs
| Diclofenac | 24 | $1,689 | $70 |
| Diclofenac | 28 | $1,240 | $44 |
| Hydrocodone-Acetaminophen | 107 | $694 | $6 |
| Meloxicam | 87 | $600 | $7 |
| Oxycodone-Acetaminophen | 13 | $104 | $8 |
| Tramadol | 13 | $55 | $4 |
2018: 8 drugs
| Diclofenac | 25 | $2,451 | $98 |
| Diclofenac | 21 | $957 | $46 |
| Meloxicam | 80 | $533 | $7 |
| Hydrocodone-Acetaminophen | 53 | $400 | $8 |
| Oxycodone-Acetaminophen | 28 | $363 | $13 |
| Naproxen | 15 | $216 | $14 |
| Warfarin | 11 | $207 | $19 |
| Gabapentin | 20 | $122 | $6 |
2017: 5 drugs
| Diclofenac | 57 | $2,714 | $48 |
| Diclofenac | 12 | $861 | $72 |
| Oxycodone-Acetaminophen | 42 | $340 | $8 |
| Hydrocodone-Acetaminophen | 50 | $317 | $6 |
| Meloxicam | 66 | $274 | $4 |
2016: 5 drugs
| Diclofenac | 43 | $2,032 | $47 |
| Diclofenac | 20 | $620 | $31 |
| Oxycodone-Acetaminophen | 36 | $415 | $12 |
| Hydrocodone-Acetaminophen | 49 | $398 | $8 |
| Meloxicam | 61 | $369 | $6 |
2015: 5 drugs
| Diclofenac | 79 | $2,609 | $33 |
| Meloxicam | 101 | $651 | $6 |
| Diclofenac | 13 | $596 | $46 |
| Hydrocodone-Acetaminophen | 42 | $346 | $8 |
| Oxycodone-Acetaminophen | 22 | $226 | $10 |
2014: 7 drugs
| Diclofenac | 24 | $921 | $38 |
| Voltaren | 20 | $878 | $44 |
| Diclofenac | 21 | $624 | $30 |
| Hydrocodone-Acetaminophen | 47 | $450 | $10 |
| Meloxicam | 53 | $382 | $7 |
| Naproxen | 19 | $189 | $10 |
| Ibuprofen | 13 | $133 | $10 |
2013: 3 drugs
| Diclofenac | 69 | $1,582 | $23 |
| Hydrocodone-Acetaminophen | 30 | $236 | $8 |
| Naproxen | 14 | $117 | $8 |
Money from drug and device companies
$62 in 2025
| 2025 | 1 | 1 | None | $62 |
| 2024 | 2 | 2 | None | $35 |
| 2022 | 2 | 2 | None | $238 |
| 2021 | 1 | 1 | None | $22 |
| 2020 | 2 | 2 | None | $1,265 |
| 2019 | 2 | 5 | None | $300 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Real Intelligence | $62 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2025-07-23 | Real Intelligence | $62 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $35
| DePuy Synthes Sales | Lcp | $19 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $16 | 1 payment
|
2022: $238
| Smith+Nephew | Visionaire | $213 | 1 payment
|
| Orthofix Medical | Physio-Stim | $24 | 1 payment
|
2021: $22
| Evolution Surgical | None | $22 | 1 payment
|
2020: $1,265
| Evolution Surgical | None | $1,141 | 1 payment
|
| Zimmer Biomet Holdings | Accufill | $124 | 1 payment
|
2019: $300
| Stryker | Mako | $177 | 4 payments
|
| Osiris Therapeutics | Stravix | $123 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1245493881
- Licence
- CA A103986, WA MD60097526California A103986: Current · expires 2027-12-31Washington MD.MD.60097526: Expired
- Trained
- University of California, San Diego School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 2585 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2008-07-03
- NPI last updated
- 2020-11-30
- NPI record certified
- 2020-11-30
This is when the NPI record was last certified, not a medical board exam.